Document Detail

Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era.
MedLine Citation:
PMID:  19695538     Owner:  NLM     Status:  MEDLINE    
The number, specific type, and complexity of percutaneous intracardiac procedures continue to evolve. Many of these procedures require left atrial access using transseptal techniques. These approaches carry with them the potential for pericardial effusion (PE) and cardiac tamponade, particularly in the setting when intraprocedural anticoagulation is being administered. PEs and even cardiac tamponade have been documented with both diagnostic as well as therapeutic procedures. When the effusion is a complication of an intracardiac procedure, it is usually the result of a cardiac perforation. The presentation depends on several factors including the structure that is perforated, the device that caused the perforation, the baseline hemodynamic status of the patient, and the level of anticoagulation present. The incidence has varied substantially although it has been recorded with essentially all intracardiac procedures, both diagnostic and therapeutic on both the right and left side of the heart. Prompt recognition is essential so that prevention of the transition from effusion to tamponade can be attempted (e.g., by reversing anticoagulation) or the hemodynamic collapse can either be averted or treated. Clinical, radiologic, and echocardiographic assessment are each important. Pericardiocentesis can be life-saving and is a core competency for all laboratories performing invasive cardiac procedures. Systems of care must include the knowledge base, equipment, and expert echocardiographic and interventional personnel. Collaboration with noninvasive colleagues and training interventionalists who perform intracardiac interventions, both electrophysiologists and interventional cardiologists, should be required as part of every invasive program.
David R Holmes; Rick Nishimura; Rebecca Fountain; Zoltan G Turi
Related Documents :
24722688 - Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.
9140678 - Prediction of the changes in cardiac output in association with preload reduction thera...
1875438 - Cardiac output measurement in critical care patients: thoracic electrical bioimpedance ...
1550418 - Cardiac tamponade as an initial manifestation of systemic lupus erythematosus in early ...
3416328 - Lymphocyte potassium and magnesium concentrations as prognostic factors after acute myo...
6696538 - Coronary artery disease in peripheral vascular patients. a classification of 1000 coron...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  JACC. Cardiovascular interventions     Volume:  2     ISSN:  1876-7605     ISO Abbreviation:  JACC Cardiovasc Interv     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-21     Completed Date:  2009-10-29     Revised Date:  2014-09-05    
Medline Journal Info:
Nlm Unique ID:  101467004     Medline TA:  JACC Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  705-17     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon, Coronary / adverse effects
Anticoagulants / adverse effects
Balloon Occlusion
Blood Pressure Determination
Cardiac Catheterization / adverse effects*
Cardiac Tamponade / etiology*,  physiopathology,  prevention & control
Catheter Ablation / adverse effects
Catheterization / adverse effects
Clinical Competence
Heart Valve Prosthesis Implantation / adverse effects
Iatrogenic Disease*
Pacemaker, Artificial / adverse effects
Pericardial Effusion / diagnosis,  etiology*,  physiopathology,  surgery
Predictive Value of Tests
Punctures / adverse effects
Risk Factors
Treatment Outcome
Reg. No./Substance:
Comment In:
JACC Cardiovasc Interv. 2010 Jan;3(1):127; author reply 127-8   [PMID:  20129583 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrop...
Next Document:  2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy b...